Main
>
ONCOLOGY (**)
>
Lung>NSCLC>MET>PD-L1+>> ***
>
Treatment
>
USA. M. PembrolizuMAb
>
(*) EU Approval Date: 2017. 01.31.
(*) EU Approval Date: 2017. 01.31.'s products
This section has no products